CD4 and inflammatory bowel disease: Previous reports suggested that CD4+ T cells were enriched in inflammatory tissues of Crohn’s and UC patients, and blockade or depletion of CD4+ T is effective in treating patients with IBD (35, 36). Since we observed UroA-mediated protective activities against colitis, we asked whether UroA treatment has any impact on T cell population in mLNs.